Clinical Trial Update: Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP

View source ↗

Summary

This clinical trial update notes that cisgender female participants may start long-acting cabotegravir for HIV PrEP, with the study currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: Midway Specialty Care Center | Conditions: Hiv | Status: ACTIVE_NOT_RECRUITING